沙特阿拉伯血糖试纸市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

沙特阿拉伯血糖试纸市场 – 行业趋势及 2031 年预测

  • Medical Devices
  • Published Report
  • Mar 2024
  • Country Level
  • 350 页面
  • 桌子數: 17
  • 图号: 58

Saudi Arabia Blood Glucose Test Strip Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 133.70 Million
Diagram Market Size (Forecast Year)
USD 179.18 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>沙特阿拉伯血糖试纸市场,按类型(厚膜电化学膜、薄膜电化学膜和光学试纸)、技术(葡萄糖氧化酶和葡萄糖脱氢酶)、方式(使用和投掷和内置指示器)、定价(标准和高级)、样品(全血和血浆)、购买方式(非处方和处方药)、包装(50 条、100 条和 25 条)、年龄组(成人、老年人和儿童)、应用(2 型糖尿病、1 型糖尿病、糖尿病前期和妊娠期糖尿病)、最终用户(家庭医疗保健、医院、诊断实验室等)、分销渠道(零售、直接招标等)划分 - 行业趋势和预测到 2031 年。

沙特阿拉伯血糖试纸市场分析与洞察

推动沙特阿拉伯血糖试纸市场增长的因素是糖尿病患病率的不断上升以及不活跃的生活方式、不健康的饮食习惯、肥胖和人口老龄化等危险因素的日益流行,导致被诊断患有糖尿病的人数不断增加。

沙特阿拉伯血糖试纸市场沙特阿拉伯血糖试纸市场

Data Bridge Market Research 分析,沙特阿拉伯血糖试纸市场在 2024 年至 2031 年的预测期内以 3.8% 的复合年增长率增长,预计到 2031 年将从 2023 年的 1.337 亿美元增至 1.7918 亿美元。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(百万美元)

涵盖的领域

类型(厚膜电化学膜、薄膜电化学膜和光学试纸)、技术(葡萄糖氧化酶和葡萄糖脱氢酶)、方式(使用和投掷以及内置指示器)、定价(标准和高级)、样品(全血和血浆)、购买方式(非处方和处方药)、包装(50 条、100 条和 25 条)、年龄组(成人、老年人和儿童)、应用(2 型糖尿病、1 型糖尿病、糖尿病前期和妊娠期糖尿病)、最终用户(家庭医疗保健、医院、诊断实验室等)、分销渠道(零售、直接招标等)

涵盖的市场参与者

Abbott、F. Hoffmann-La Roche Ltd.、Ascensia Diabetes Care Holdings AG.、LifeScan IP Holdings, LLC.、EASYMAX Diabetes Care、Sinocare、Bionime Corporation.、ARKRAY, Inc.、Trister 和 General Life Biotechnology Co., Ltd. 等

市场定义

血糖试纸是医学诊断领域的一个重要组成部分,专门用于监测和管理糖尿病。这些小型的一次性试纸配备了专门的化学物质,可以与血液样本中的葡萄糖发生反应。这些试纸通常与血糖仪一起使用,使糖尿病患者能够在家中或临床环境中准确、方便地测量血糖水平。

沙特阿拉伯血糖试纸市场动态

驱动程序

  • 糖尿病患病率上升

缺乏运动的生活方式、不健康的饮食习惯、肥胖和人口老龄化等风险因素的日益盛行,导致越来越多的人被诊断患有糖尿病。随着越来越多的人患有糖尿病,糖尿病管理产品(包括血糖试纸)的市场也越来越大。对于糖尿病患者来说,定期监测血糖水平对于控制病情和预防并发症至关重要。血糖试纸可让患者在家中或外出时监测血糖水平,提供有价值的信息来指导饮食选择、药物剂量和生活方式的改变。随着糖尿病变得越来越普遍,有效血糖监测的重要性越来越受到重视,从而推动了对试纸的需求。

  • 自我监测的普及度不断提高

自我监测使糖尿病患者能够根据其独特的血糖模式和波动情况制定个性化治疗计划,并跟踪血糖水平随时间的变化,患者可以识别趋势、识别模式,并就药物调整、饮食调整和生活方式干预做出明智的决定。这种个性化的糖尿病管理方法可以更好地控制血糖并改善健康状况,从而推动了对血糖测试条的需求,使其成为自我监测的重要工具。

沙特阿拉伯血糖试纸市场

机会

  • 越来越重视疾病管理和预防保健

随着人们越来越重视疾病管理和预防保健,人们越来越认识到早期发现和干预糖尿病等慢性疾病的重要性。血糖试纸在促进早期发现方面发挥着至关重要的作用,因为它允许人们定期监测血糖水平。早期发现可以及时采取干预措施,例如改变生活方式或调整药物,以防止或延缓糖尿病并发症的发生。

克制

  • 严格的审批监管标准

监管机构对血糖试纸施加了严格的性能标准,以确保准确性、可靠性和安全性。制造商必须证明其试纸符合灵敏度、特异性、精确度和线性度的特定标准,这通常需要进行大量的测试和验证研究。满足这些性能标准可能具有挑战性,特别是对于新技术或创新方法而言,这会导致产品开发和上市延迟。

挑战

  • 血糖试纸的成本和可负担性

患者和医疗保健提供者在选择血糖试纸时对价格越来越敏感,特别是在医疗资源有限或自付费用较高的地区。注重价格的消费者可能会选择成本较低的替代品或通用试纸来省钱,从而牺牲准确性或可靠性。价格敏感性可能导致制造商之间的价格竞争,从而降低利润率并减缓市场增长。

最新动态

  • 2023 年 10 月,根据《药品配送商业新闻》报道,雅培凭借其连续血糖监测 (CGM) 技术成为糖尿病领域的市场领导者之一。该公司继续更新其 FreeStyle Libre 2 CGM,并在去年获得 FDA 批准后开始推出 FreeStyle Libre 3。这可能有助于该公司在糖尿病管理和护理领域确立强大的地位
  • 2023 年 5 月,Ascensia Diabetes Care 将扩大其 Eversense PASS 计划,旨在提高先进 Eversense E3 CGM 系统的可负担性和可访问性。该计划为符合条件的首次用户提供更多节省,反映了 Ascensia 致力于扩大可访问性并减轻需要先进血糖监测解决方案的个人的财务障碍的承诺。它将提高患者的保留率
  • 2022 年 1 月,F Hoffmann La Roche 与 Glytec 达成战略协议,Glytec 是一家基于云的胰岛素管理软件供应商,业务涉及整个护理过程。为了解决住院患者在医院床边的血糖管理问题,此次数字健康合作将罗氏在医疗设备和 IT 解决方案方面的专业知识与 Glytec 经 FDA 批准的胰岛素给药决策支持软件 Glucommander 结合起来。Glucommander 将成为罗氏 Cobas pulse 智能设备下一代医院血糖系统的第一个软件程序,该系统旨在通过允许护理点医生实时收集和处理血糖管理数据来改善患者安全和护理

沙特阿拉伯血糖试纸市场范围

沙特阿拉伯血糖试纸市场根据类型、技术、模式、定价、样品、购买方式、包装、年龄组、应用、最终用户和分销渠道细分为 11 个值得注意的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。

类型

  • 厚膜电化学膜
  • 薄膜电化学膜
  • 光学条

根据类型,市场分为厚膜电化学膜、薄膜电化学膜和光学条

技术

  • 葡萄糖氧化酶
  • 葡萄糖脱氢酶

根据技术,市场分为葡萄糖氧化酶和葡萄糖脱氢酶。

情态

  • 使用并抛出
  • 内置指示器

根据形式,市场分为使用和抛出以及内置指示器。

价格

  • 标准
  • 优质的

根据定价,市场分为标准市场和高级市场。

样本

  • 全血
  • 等离子体

根据样本,市场分为全血和血浆。

购买方式

  • 在柜台
  • 处方药

根据购买方式,市场分为非处方药和处方药。

包装

  • 50 条
  • 100 条
  • 25 条

根据包装,市场分为 50 条、100 条和 25 条。

年龄组

  • 成人
  • 老年
  • 儿科

根据年龄组,市场分为成人、老年人和儿童

应用

  • 2 型糖尿病
  • 1 型糖尿病
  • 糖尿病前期
  • 妊娠糖尿病

根据应用,市场分为 2 型糖尿病、1 型糖尿病、糖尿病前期和妊娠期糖尿病

最终用户

  • 家庭医疗保健
  • 医院
  • 诊断实验室
  • 其他的

根据最终用户,市场分为家庭医疗保健、医院、诊断实验室和其他。

分销渠道

  • 零售销售
  • 直接招标
  • 其他的

根据分销渠道,市场细分为零售、直接招标和其他

沙特阿拉伯血糖试纸市场

竞争格局和沙特阿拉伯血糖试纸市场份额分析

沙特阿拉伯血糖试纸市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、公司优势和劣势、产品发布、产品批准、应用主导地位和产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。

该市场的一些主要市场参与者包括 F. Hoffmann-La Roche Ltd.、LifeScan IP Holdings, LLC.、Abbott Ascensia Diabetes Care Holdings AG. 和 Sinocare 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET : SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 MARKET PRACTICES

4.4 PRICING AND MARIGIN ANALYSIS

4.5 VOLUMETRIC ANALYSIS

4.6 MAIN TENDERS ANALYSIS

4.7 TECHNICAL PREFERENCES:

4.8 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: PROCUREMENT PROCESS

4.8.1 THROUGH NUPCO

4.8.2 REQUIREMENTS FOR REGULATORY REGISTRATION AND TENDER APPLICATIONS:

4.9 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, REIMBURSEMENT SCENARIO

4.9.1 TYPE 1 DIABETES

4.9.2 TYPE 2 DIABETES

4.9.3 PRE-DIABETES

5 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, REGULATORY FRAMEWORK

5.1 OV,ERVIEW OF THE REGULATORY FRAMEWORK FOR BLOOD GLUCOSE STRIPS IN SAUDI ARABIA

5.2 REGULATORY FRAMEWORK FOR PUBLIC AND PRIVATE BLOOD GLUCOSE TEST STRIPS MARKET IN SAUDI ARABIA

5.2.1 REGULATIONS IN THE PUBLIC MARKET

5.2.2 REGULATIONS IN PUBLIC MARKET

5.3 REGULATORY FRAMEWORK FOR URBAN AND RURAL BLOOD GLUCOSE TEST STRIPS MARKET IN SAUDI ARABIA

5.4 REGISTRATION PROCESS AND REQUIREMENTS FOR RETAIL MARKET

5.4.1 PREPARATION AND DOCUMENTATION

5.4.2 SUBMISSION OF APPLICATION

5.4.3 REVIEW AND EVALUATION

5.4.4 SFDA APPROVAL

5.4.5 POST-MARKET SURVEILLANCE

5.4.6 RENEWAL AND MAINTENANCE

5.5 REGULATIONS FOR EXPIRED BLOOD GLUCOSE TEST STRIPS IN SAUDI ARABIA

5.5.1 HEALTHCARE WASTE MANAGEMENT

5.5.2 PRODUCT RECALL AND RETURN POLICIES

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE OF DIABETES

6.1.2 GROWING ADOPTION OF SELF-MONITORING

6.1.3 RISING TECHNOLOGICAL ADVANCEMENTS IN BLOOD GLUCOSE TEST STRIP

6.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES IN BLOOD GLUCOSE TEST STRIP

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATORY STANDARD FOR APPROVAL

6.2.2 ACCURACY AND RELIABILITY CONCERNS ASSOCIATED WITH BLOOD GLUCOSE TEST STRIPS

6.3 OPPORTUNITIES

6.3.1 GROWING EMPHASIS ON DISEASE MANAGEMENT AND PREVENTIVE CARE

6.3.2 GROWING DEMAND FOR POINT-OF-CARE TESTING

6.3.3 RISING HEALTHCARE EXPENDITURE

6.4 CHALLENGES

6.4.1 COST AND AFFORDABILITY OF BLOOD GLUCOSE TEST STRIPS

6.4.2 INADEQUATE REIMBURSEMENT FOR TEST STRIPS

7 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, BY TYPE

7.1 OVERVIEW

7.2 THICK FILM ELECTROCHEMICAL FILMS

7.3 THIN FILM ELECTROCHEMICAL FILMS

7.4 OPTICAL STRIPS

8 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 GLUCOSE OXIDASE

8.3 GLUCOSE DEHYDROGENASE

9 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, BY MODALITY

9.1 OVERVIEW

9.2 USE AND THROW

9.2.1 TYPE 2 DIABETES

9.2.2 TYPE 1 DIABETES

9.2.3 PRE-DIABETES

9.2.4 GESTATIONAL DIABETES

9.3 BUILT-IN INDICATOR

9.3.1 TYPE 1 DIABETES

9.3.2 TYPE 2 DIABETES

9.3.3 PRE-DIABETES

9.3.4 GESTATIONAL DIABETES

10 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY PRICING

10.1 OVERVIEW

10.2 STANDARD

10.3 PREMIUM

11 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY SAMPLE

11.1 OVERVIEW

11.2 WHOLE BLOOD

11.3 PLASMA

12 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY MODE OF PURCHASE

12.1 OVERVIEW

12.2 OVER THE COUNTER

12.3 PRESCRIPTION BASED

13 SAUDI ARABIA HOSPITALS IN BLOOD GLUCOSE TEST STRIP MARKET, BY PACKAGING

13.1 OVERVIEW

13.2 50 STRIPS

13.3 100 STRIPS

13.4 25 STRIPS

14 SAUDI ARABIA HOSPITALS IN BLOOD GLUCOSE TEST STRIP MARKET, BY AGE GROUP

14.1 OVERVIEW

14.2 ADULT

14.3 GERAITRIC

14.4 PEDIATRIC

15 SAUDI ARABIA HOSPITALS IN BLOOD GLUCOSE TEST STRIP MARKET, BY APPLICATIONS

15.1 OVERVIEW

15.2 TYPE 2 DIABETES

15.3 TYPE 1 DIABETES

15.4 PRE-DIABETES

15.5 GESTATIONAL DIABETES

16 SAUDI ARABIA HOSPITALS IN BLOOD GLUCOSE TEST STRIP MARKET, BY END USER

16.1 OVERVIEW

16.2 HOME HEALTHCARE

16.3 HOSPITALS

16.3.1 PRIVATE

16.3.2 PUBLIC

16.4 DIAGNOSTIC LABORATORIES

16.5 OTHERS

17 SAUDI ARABIA HOSPITALS IN BLOOD GLUCOSE TEST STRIP MARKET, BY DISTRIBUTION CHANNEL

17.1 OVERVIEW

17.2 RETAIL SALES

17.2.1 HOSPITAL PHARMACY

17.2.2 DRUG STORES

17.2.3 ONLINE PHARMACY

17.3 OTHERS

18 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: SAUDI ARABIA

19 COMPANY PROFILE

19.1 F. HOFFMANN-LA ROCHE LTD

19.1.1 COMPANY SNAPSHOT

19.1.2 REVENUE ANALYSIS

19.1.3 PRODUCT PORTFOLIO

19.1.4 RECENT DEVELOPMENTS

19.2 LIFESCAN IP HOLDINGS, LLC

19.2.1 COMPANY SNAPSHOT

19.2.2 PRODUCT PORTFOLIO

19.2.3 RECENT DEVELOPMENTS

19.3 ABBOTT

19.3.1 COMPANY SNAPSHOT

19.3.2 REVENUE ANALYSIS

19.3.3 PRODUCT PORTFOLIO

19.3.4 RECENT DEVELOPMENT

19.4 ASCENSIA DIABETES CARE HOLDINGS AG.

19.4.1 COMPANY SNAPSHOT

19.4.2 PRODUCT PORTFOLIO

19.4.3 PRODUCT PORTFOLIO

19.5 SINOCARE INC.

19.5.1 COMPANY SNAPSHOT

19.5.2 PRODUCT PORTFOLIO

19.5.3 RECENT DEVELOPMENTS

19.6 ARKRAY, INC.

19.6.1 COMPANY SNAPSHOT

19.6.2 PRODUCT PORTFOLIO

19.6.3 RECENT DEVELOPMENT

19.7 BIONIME CORPORATION

19.7.1 COMPANY SNAPSHOT

19.7.2 PRODUCT PORTFOLIO

19.7.3 RECENT DEVELOPMENT

19.8 EASYMAX DIABETES CARE

19.8.1 COMPANY SNAPSHOT

19.8.2 PRODUCT PORTFOLIO

19.8.3 RECENT DEVELOPMENT

19.9 GENERAL LIFE BIOTECHNOLOGY CO., LTD.

19.9.1 COMPANY SNAPSHOT

19.9.2 PRODUCT PORTFOLIO

19.9.3 RECENT DEVELOPMENT

19.1 TRISTER

19.10.1 COMPANY SNAPSHOT

19.10.2 PRODUCT PORTFOLIO

19.10.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

表格列表

TABLE 1 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP PRICING AND PROFIT MARGIN (2023)

TABLE 2 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (UNITS)

TABLE 3 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 4 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 5 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 6 SAUDI ARABIA USE AND THROW IN BLOOD GLUCOSE TEST STRIP MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 7 SAUDI ARABIA BUILT-IN INDICATOR IN BLOOD GLUCOSE TEST STRIP MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 8 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY PRICING, 2022-2031 (USD MILLION)

TABLE 9 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY SAMPLE, 2022-2031 (USD MILLION)

TABLE 10 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)

TABLE 11 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY PACKAGING, 2022-2031 (USD MILLION)

TABLE 12 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 13 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY APPLICATIONS, 2022-2031 (USD MILLION)

TABLE 14 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 15 SAUDI ARABIA HOSPITALS IN BLOOD GLUCOSE TEST STRIP MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 16 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 17 SAUDI ARABIA RETAIL SALES IN BLOOD GLUCOSE TEST STRIP MARKET, BY TYPE, 2022-2031 (USD MILLION)

图片列表

FIGURE 1 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: SEGMENTATION

FIGURE 2 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: DATA TRIANGULATION

FIGURE 3 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: DROC ANALYSIS

FIGURE 4 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: COUNTRY WISE MARKET ANALYSIS

FIGURE 5 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 THE SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET : DBMR POSITION GRID

FIGURE 8 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: END USER COVERAGE GRID

FIGURE 10 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: SEGMENTATION

FIGURE 11 THE ESCALATING PREVALENCE OF DIABETES AND THE INCREASING ADOPTION OF SELF-MONITORING PRACTICES AMONG INDIVIDUALS WITH DIABETES IS EXPECTED TO DRIVE THE SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET FROM 2024 TO 2031

FIGURE 12 THICK FILM ELECTROCHEMICAL FILMS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET FROM 2024 TO 2031

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET

FIGURE 14 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TYPE, 2023

FIGURE 15 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TYPE, 2024-2031 (USD MILLION)

FIGURE 16 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 17 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 18 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TECHNOLOGY, 2023

FIGURE 19 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TECHNOLOGY, 2024-2031 (USD MILLION)

FIGURE 20 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TECHNOLOGY, CAGR (2024-2031)

FIGURE 21 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 22 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY MODALITY, 2023

FIGURE 23 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY MODALITY, 2024-2031 (USD MILLION)

FIGURE 24 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY MODALITY, CAGR (2024-2031)

FIGURE 25 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 26 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PRICING, 2022

FIGURE 27 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PRICING, 2024-2031 (USD MILLION)

FIGURE 28 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PRICING, CAGR (2024-2031)

FIGURE 29 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PRICING, LIFELINE CURVE

FIGURE 30 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY SAMPLE, 2022

FIGURE 31 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY SAMPLE, 2024-2031 (USD MILLION)

FIGURE 32 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY SAMPLE, CAGR (2024-2031)

FIGURE 33 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY SAMPLE, LIFELINE CURVE

FIGURE 34 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY MODE OF PURCHASE, 2023

FIGURE 35 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)

FIGURE 36 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)

FIGURE 37 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 38 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PACKAGING, 2023

FIGURE 39 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PACKAGING, 2024-2031 (USD MILLION)

FIGURE 40 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PACKAGING, CAGR (2024-2031)

FIGURE 41 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY PACKAGING, LIFELINE CURVE

FIGURE 42 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY AGE GROUP, 2023

FIGURE 43 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY AGE GROUP, 2024-2031 (USD MILLION)

FIGURE 44 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY AGE GROUP, CAGR (2024-2031)

FIGURE 45 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 46 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY APPLICATIONS, 2023

FIGURE 47 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY APPLICATIONS, 2024-2031 (USD MILLION)

FIGURE 48 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY APPLICATIONS, CAGR (2024-2031)

FIGURE 49 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY APPLICATIONS, LIFELINE CURVE

FIGURE 50 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY END USER, 2023

FIGURE 51 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 52 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY END USER, CAGR (2024-2031)

FIGURE 53 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY END USER, LIFELINE CURVE

FIGURE 54 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 55 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 56 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 57 SAUDI ARABIA BLOOD GLUCOSE TEST STRIP MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 58 SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET: COMPANY SHARE 2023 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Saudi Arabia blood glucose test strip market size will be worth USD 179.18 million by 2031.
The growth rate of the Saudi Arabia blood glucose test strip market is 3.8%.
Rising prevelance of diabetes & growing adoption of self-monitoring are the growth drivers of the Saudi Arabia blood glucose test strip market.
type, technology, modality, pricing, sample, mode of purchase, packaging, age group, application, end user, and distribution channel are the factors on which the Saudi Arabia blood glucose test strip market research is based.
Major companies in the Saudi Arabia blood glucose test strip market are Abbott, , F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care Holdings AG. ,LifeScan IP Holdings, LLC., EASYMAX Diabetes Care, Sinocare, Bionime Corporation., ARKRAY, Inc., Trister, and General Life Biotechnology Co., Ltd. among others.